Showing results (51-60 of 7,431) with videos related to
Sort By:
Pageof 744
Neuroscience Letters|October 14, 1991
The human sigma site, which resembles that in NCB20 cells, may correspond to a low-affinity site in guinea pig brainA R Knight, J Gillard, E H Wong, et al.Journal of Neurochemistry|March 1, 1986
Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brainD N Middlemiss, A M Palmer, N Edel, et al.Neuroscience Letters|October 23, 1989
MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtypeB H King, C Brazell, C T Dourish, et al.British Journal of Pharmacology|January 12, 1999
Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptorsJ Watson, S Brough, M C Coldwell, et al.European Journal of Pharmacology|October 29, 1985
Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the ratM D Tricklebank, C Forler, D N Middlemiss, et al.Schizophrenia Research|March 23, 2000
Interactive ERP recording increases the amplitude of the endogenous P300 peak in schizophreniaG W PriceBrain Topography|April 1, 1997
The effect of pre-stimulus alpha activity on the auditory P300 paradigm: a prospective studyG W PriceBritish Journal of Pharmacology|August 6, 2000
Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonistC Routledge, S M Bromidge, S F Moss, et al.Biochemical Pharmacology|January 1, 1982
K+-evoked [3H]-5-HT release from rat frontal cortex slices: the effect of 5-HT agonists and antagonistsI Mounsey, K A Brady, J Carroll, et al.Trends in Pharmacological Sciences|May 1, 1997
Parkinson's disease: prospects for improved drug therapyJ J Hagan, D N Middlemiss, P C Sharpe, et al.Pageof 744